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ABSTRACT 
 
Background.  While various medical treatments have been proven 
effective in the treatment of sepsis in animal models, the only current 
clinically accepted treatment of human sepsis is limited to the use of 
activated protein C.  The complex pathogenesis of human sepsis presents a 
challenge in precisely duplicating the process of disease development in 
the particular animal models which are currently employed for preclinical 
testing.  Further research examining the pathogenesis of this deadly 
condition is essential for the implementation of novel therapies that target 
distinct disease mechanisms.  The objective of this 48-hour study is to 
utilize a clinical model that accurately replicates severe human sepsis 
along with gut ischemia/reperfusion (I/R).  I/R further leads to the injury 
of multiple organs within the time period most closely mirroring disease 
progression in humans. 
 Methodology.  The experimental protocol was approved by the 
Committee for the Humane Use of Animals at SUNY Upstate Medical 
University and complied with the National Institutes of Health Guidelines 
for the Use of Experimental Animals in Research. Five pigs were 
subjected to a “two-hit” injury involving the clamping of the superior 
mesenteric artery (SMA) for 30 minutes as well as a laparotomy used for 
insertion of a fecal clot, following appropriate administration of 
anesthetics and ventilation.  A drain was inserted into this laparatomy 
wound twelve hours post injury.  Monitoring of animals took place under 
a standard Intensive Care Unit setting over the course of 48 hours, with 
oxygen desaturation resolved by increasing FiO2.  Hemodynamics were 
stabilized through administration of antibiotics and intravenous fluids as 
needed, while measurements of arterial and mixed venous blood gases as 
well as lung, kidney, liver, renal, and hemodynamic function 
measurements were recorded.  Progression of the abdominal compartment 
syndrome was determined by monitoring bladder pressure changes.  Serial 
measurements of peritoneal and plasma ascites were also taken for 
evaluation of cytokine concentration.  Morphometric analysis was carried 
out using the organ tissues harvested and fixed at necropsy. 
 Results.  All animals presented with polymicrobial sepsis.  Over 
the course of 48 hours the lung, liver, kidney, and intestine showed 
ongoing deterioration and histopathological as well as clinical damage.  
This was found to occur in conjunction with increased levels of cytokines 
within the peritoneal fluid and serum. 
 Conclusion.  In combining both sepsis and ischemia reperfusion 
injury, the animal model used in this study is valid for uncovering the 
intricate pathophysiological progression of septic shock and its transition 
to multiple organ dysfunction syndrome.  This system mirrors the 
systemic inflammation and major organ systems dysfunction seen in 
humans.  Through demonstrating the success of the current animal model, 
   
prospective treatments may be developed through conducting 
sophisticated preclinical trials. 
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INTRODUCTION 
 
As the leading cause of hospitalized adult patients in the intensive 
care unit, 1.8 million cases of sepsis have been reported annually with 
nearly 2,000 deaths daily resulting from sepsis [1].  Human sepsis is 
typically caused by a site of infection containing replicating bacteria that 
persist for an extensive period of time.  It is a syndrome that usually 
evolves in a continuum from systemic inflammatory response syndrome 
(SIRS) to sepsis combined with organ dysfunction, and to septic shock.  
As the severity of the disease increases, the frequency rate of positive 
blood cultures increases (sepsis [17%], severe sepsis [25%], septic shock 
[69%], suggesting that bacterial invasion can predict the expected disease 
outcome and mortality risk [2].  The mortality rate of these three stages is 
25%, 30%, and 40-70%, respectively [3].   
Animal studies are not easy to extrapolate to true clinical settings 
due to cross-species differences and variations in experimental design. 
Septic spread can be attributed to a series of causes including the state of 
activation of the target cell, the presence of nearby mediators, and the 
ability of the target cell to release other mediators.  Animal studies have 
shed light on how such processes occur by analyzing apoptosis, 
fibrinolysis, organ and hormone function, tissue perfusion, and 
coagulation in animal models.  Pathogens interact with the host immune 
response throughout the progression of the disease, leading from 
inflammation to immunosuppression via numerous mediators, such as 
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tumor necrosis factor α (TNF-α), interleukins, platelet activating factor, 
leukotrienes, thromboxane A2, and activators of the complement cascade.  
Also important is the negative feedback of various mediators along with 
interleukin-4 and interleukin-8, which act as natural inflammatory 
suppressors.  This shows that disease progression depends on the proper 
coordination and function of not only up-regulatory systemic factors, but 
also of down-regulatory that can be essential in active protection against 
infection.   
Currently, protocolized management in the form of early goal 
oriented therapy is used in addressing preventative and early onset 
treatment of sepsis.  Exogenous administration of activated protein C is 
used to support severely septic patients.  Only experiments with relevant 
subjects, can develop the monitoring, diagnostic, and ventilation 
modalities that can lead to improved treatment of sepsis in eluding more 
effective patient support.  Animal studies generally allow an opportunity 
for intervention even in the early stages of sepsis, when inflammatory 
cytokine levels continue to increase even though organ damage and 
vascular leakage are still minimal.  In humans however, most treatments 
are started at a time when organ damage is already present, when many 
patients have activated a deleterious anti-inflammatory response following 
the protective proinflammatory response.  Because proactive fluid therapy 
is rarely used in animal models, the effect of ventilators and vasopressors 
on a drug response is difficult to evaluate. In human sepsis, ubiquitous 
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mixed infections containing both Gram-negative and Gram-positive 
bacteria predominate with antibiotic treatment remaining only partially 
effective, unlike in animal models where the appropriate antibiotic may be 
selected to control bacterial proliferation [4].   
For the aforesaid reasons, a novel model of clinical relevance was 
implemented, emulating early sepsis progression through gradual organ 
function degradation and chronic pathogenesis evidenced by classic 
histopathologic abnormalities of sepsis observed in the liver, intestine, and 
kidney.  This was made possible by conducting a “two-hit” injury model 
combining intraperitoneal infection and intestinal ischemia and 
reperfusion.  This anatomically relevant, clinically applicable, unbiased 
replication of the progression of sepsis demonstrates a model that is 
expected to produce promising treatment options and in turn, the 
possibility of successful future clinical trials.   
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MATERIALS AND METHODS 
 
 The experiments performed under this study were approved by the 
Committee for the Humane Use of Animals at SUNY Upstate Medical 
University and complied with the National Institutes of Health Guidelines 
for the Use of Experimental Animals in Research [5]. 
 A total of five pigs were used in this study, with a separate 
experiment conducted on each pig.  None of the animals presented with 
co-morbidities at the start of the experiment, ensuring that outlying factors 
did not interfere with induced disease progression. 
Anesthesia 
Healthy female Yorkshire pigs weighing from 22 to 30 kg were 
treated intramuscularly with 0.01 mg/kg of glycopyrrolate, 5 mg/kg of 
telazol, and 2 mg/kg of xylazine prior to the start of the experiment.  A 3 
mg/mL ketamine plus xylazine (0.3 mg/mL) infusion was continuously 
administered using a 3M model 3000 infusion pump.  This held the 
anesthesia rate steady at 100 mL/h throughout the duration of the 
experiment.  All necessary adjustments to anesthesia administration rate 
were noted [5]. 
Tracheostomy and Mechanical Ventilation 
Upon performing a tracheostomy the animals were connected to a 
Galileo ventilator (Hamilton Medical, Reno, NV).  Low tidal volume 
mechanical ventilation was omitted in order to measure the progression of 
potential lung injury.  The initial parameters were set to the following: 
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tidal volume (vt) 12 cc/kg, 15/mm titrated respiratory rate (RR) to 
maintain normal PaCO2, 21% FiO2, and 3 cmH20 positive end-expiratory 
pressure (PEEP) [5]. 
Surgical Preparation 
Blood chemistry, gas content, and arterial pressure measurements 
were collected via a left carotid artery catheter placed under sterile 
conditions.  A triple lumen catheter was placed following a 4 cm right 
lateral neck incision and veinotomy.  Antibiotics, fluids, and anesthesia 
were administered through this route.  Pulmonary arterial pressure (PAP) 
and pulmonary artery wedge pressure (PAW), mixed venous blood gas 
collection, and cardiac output (CO), were all monitored using the inserted 
right internal jugular Swan-Ganz catheter.  A Foley catheter inserted into 
the bladder allowed for measurements and analysis of urine output 
samples as well as bladder pressure monitoring via its connection to a 
pressure transducer leveled at mid-axillary line [5]. 
Injury 
 After performing a midline laparatomy, the superior mesenteric 
artery (SMA) was clamped for 30 minutes.  Bowel discoloration as well as 
loss of mesenteric pulse confirmed that intestinal ischemia was indeed 
induced.  The SMA was unclamped after 30 minutes and a fecal-blood 
clot was created following a 2 centimeter cecum enterotomy, from which 
0.5 cc/kg of feces were obtained and combined with 22 cc/kg of blood.  
With the enterotomy remaining, the cecum was returned to its anatomical 
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position and the clot was implanted into the lower right quadrant of the 
abdominal cavity.  Peritoneal fluids were collected via a catheter placed in 
the Morrison’s pouch and sutured to the skin outside of the body wall.  T0 
(signifying zero hours following injury) was the recorded time after the 
suturing of the abdomen. Twelve hours after injury (T12), the midline 
incision was reopened and abdomen was decompressed and allowed to 
passively drain for collection of ascites, which was flash-frozen to allow 
for examination of inflammatory mediators.  Each animal was monitored 
for a total of 48 hours or until time of death [5]. 
Fluids and Antibiotics 
 A water bath was used to warm all fluids to 37°C.  Prior to injury, 
animals were given a fluid bolus of lactated ringer (1 L, i.v.) over 30 
minutes.  After the T0 measurement, ampicillin (2g, i.v.) and flagyl (500 
mg, i.v.) were administered over the course of 15 minutes, with this 
administration repeated at T12, T24, and T36.  Mean arterial pressure 
(MAP) and urine output (UOP) were used as markers to adjust the 
intravenous infusion of lactated ringers, ensuring adequate volume status 
(UOP of above 0.5 cc/kg/h and MAP above 60mmHg).  Fluid infusion or 
extraction recordings allowed for analysis of fluid balance throughout the 
experiment [5]. 
Ventilator Adjustments 
If arterial saturation (SaO2) dropped below 92%, oxygenation was 
maintained by increasing FiO2.  If this was inadequate, PEEP was 
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increased in increments of 2 cmH20, with pancuronium bromide (0.1 
mg/kg, i.v.) administered to control breathing in the case of triggered 
ventilations while the pig was sedated [5]. 
Hemodynamic Measurements 
 All physiologic measurements were taken hourly, from T0 to T48.  
Edwards transducers were used for ECG monitoring as well as pulse 
oximetry, mean arterial pressure (MAP), central venous pressure (CVP), 
pulmonary artery pressure (PAP), and pulmonary artery wedge pressure 
(PAW) measurements.  Cardiac output (CO) was measured by injecting 
three boluses of cold dextrose 5% and sodium chloride 0.45% solution at 
end-expiration and taking the average of the three separate measurements 
[5]. 
Pulmonary Function Measurements 
All lung function parameters were recorded hourly, from T0 to 
T48.  The following pulmonary parameters were measured using the 
Galileo ventilator: respiratory rate (RR), peak airway pressure (Pip), mean 
airway pressure (PEEP), auto PEEP, expiratory minute volume (EMV), 
and static compliance (Cstat) [5]. 
Kidney Function 
Measurements of blood creatinine levels (through SUNY Upstate 
Medical University Clinical Pathology Department) as well as BUN levels 
(using Roche Cobras b221) were taken every hour for the first 6 hours and 
every 6 hours thereafter to assess kidney function.  Measurements of UOP 
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were taken hourly and flash frozen samples of urine from T0, T12, T36, 
and T48 provided protein concentrations [5]. 
Liver Function 
Samples were submitted to the SUNY Upstate Medical University 
Clinical Pathology Department for measurement of alanine 
aminotransferase (ALT), aspartate aminotransferase (AST), albumin, total 
and direct bilirubin, total protein, and coagulation parameters, as 
indicators of synthetic liver function [5]. 
Coagulation Parameters 
Samples submitted to the SUNY Upstate Medical University 
Clinical Pathology Department were analyzed for prothrombin time (PT), 
international normalization ratio (INR), and activated partial 
thromboplastin time (PTT) [5]. 
Blood Chemistry 
A Roche blood gas analyzer was used to measure blood gases at 
baseline, hourly for the first 6 hours following injury, and every 6 hours 
thereafter.  Arterial and mixed venous blood samples were taken in order 
to measure pH, pCO2, pO2, SO2, hematocrit, hemoglobin, sodium, 
potassium, chloride, ionized calcium, glucose, lactate, and BUN [5]. 
Circulating Leukocytes and Platelets 
Samples were submitted to the SUNY Upstate Medical University 
Clinical Pathology Department for a complete blood count (CBC) with 
differential including the platelet and white blood cell (WBC) count [5]. 
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Inflammatory Mediators 
 In order to obtain plasma, the blood collected was transferred to 
sodium citrate tubes and spun at 15°C at 3500 RPM for 10 minutes.  
Analysis of inflammatory mediators was subsequently performed using 
the plasma that was removed and snap-frozen in liquid nitrogen [5]. 
 Peritoneal fluid was collected by injecting 20 mL of saline into the 
peritoneal catheter and aspirating the syringe back 1 minute later.  The 
saline plus ascites which was collected was then spun at 15°C at 3500 
RPM for 10 minutes, the supernate separated, and snap-frozen in liquid 
nitrogen for further inflammatory mediator analysis [5]. 
 The bronchoalveolar lavage fluid (BALF) was obtained at 
necropsy when 60 mL of saline was used to lavage the right middle lobe.  
The collected BALF was spun at 15°C at 3500 RPM for 10 minutes, the 
supernate separated, and snap-frozen in liquid nitrogen for further 
inflammatory mediator analysis. [5] 
 ELISA assays were used to measure other inflammatory mediators 
including tumor necrosis factor alpha (TNF-α), interleukin (IL)-8, IL-6, 
IL-1β, IL-12, transforming growth factor beta (TGF- β), and IL-10.   
 An end point chromogenic LAL assay was used to attain endotoxin 
levels.  Both anaerobic and aerobic bacteria were identified through 
analysis of the blood samples collected [5]. 
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Necropsy 
 
 Hematoxylin and eosin were used to stain all excised specimens.  
Slides of these specimens were studied microscopically and any 
histological findings were photographed under low (4x), medium (10x), 
and high (40x) magnification [5]. 
 After removal of the heart and lungs, the lungs were photographed 
after being inflated to peak airway pressure of 25cmH20.  Two samples 
were sectioned off from the most medial section 3 cm from the distal lung 
tip.  Dependent lung area specimens were sectioned off longitudinally by 
measuring 3 cm medially from the aortic grove.  The bronchus to the right 
middle lobe of the heart was exposed, the right mainstream bronchus was 
clamped, the trachea was clamped, and the left lung was filled with 10% 
neutral buffered formalin and immersed in formalin for 48 hours before 
performing histological examination [5]. 
 The kidney was divided along the central axis in order to obtain 
portions of the medulla and cortex, which were then fixed in 10% buffered 
formalin for at least 48 hours [5]. 
 Proximal, mid-jejunum, and distal portions of the small intestine 
were excised and then fixed in 10% buffered formalin for at least 48 hours 
[5]. 
 The center of the left lobe of the liver was severed in order to 
harvest a 3 cm section of liver, which was then fixed in 10% buffered 
formalin [5]. 
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Edema Measurement 
A wet weight/dry weight ratio (W/D ratio) was used to quantify 
edema measurements for the lung, kidney, intestine, and liver.  Tissues 
from each of these organs were excised, minced, weighed, and allowed to 
dry inside of an oven at 60°C.  Once the weight remained constant for a 
period of 24 hours, this dry weight was recorded.  Control animals from 
previous experiments were used as comparative models for wet and dry 
weights in this study [5]. 
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RESULTS 
Three of the five pigs died prior to reaching T48, signifying a 
mortality rate of 60%.  All five of the pigs survived to T18, 60% of the 
pigs survived to T46, and 40% of the pigs remained up to T48.  Blood 
cultures tested positive for Pseudomonas aeruginosa, Escherichia coli, 
Klebsiella pneumoniae, and Proteus mirabilis.  All animals presented with 
polymicrobial sepsis and bacteremia.  Decreased cardiac output and mean 
arterial pressure indicated hypodynamic shock and hypotension [5]. 
Table 1 shows changes in lung function and hemodynamics. A P/F 
ratio below 300 without left ventricular failure served as the indicator of 
acute lung injury (ALI) according to the consensus definition [6]. Lung 
failure was noted due to a bladder pressure rising above 20mmHg, which 
demonstrated abdominal compartment syndrome according to the 
consensus definition [7].  Increased Ppeak, Pplat, and decreased Cstat 
served as markers of lung injury.  Histological analysis further supported 
this, showing interstitial infiltration of granulocytes, as well as 
proteinaceous infiltrate evidenced by fibrinous deposits found in alveolar 
spaces as a probable correlation with focal alveolar atelectasis with dilated 
alveolar ducts.  An elevated wet-to-dry ratio as compared with control 
models indicated advanced edema as a result of lung injury [5]. 
 Blood composition changes were noted a
progressed as illustrated in Table 2.  Hemoglobin, platelets, total protein, 
and albumin markedly declined.  At the same time, hematocrit percentages 
changed significantly, along with arterial pH measurements.  WBC varied, 
but did not show significant change in connection with time.  
Liver and kidney function abnormalities are a result of numerous 
fluctuations shown on the liver function panel, kidney function 
parameters, and via coagulation assessment
Table 4.  Acute renal injury was first evidenced by a doubling of 
s the experiment 
 
 as recorded in Table 3 and 
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 creatinine levels throughout the experiments’ duration.  Increasing intra
abdominal pressure likely caused the average hourly UOP to drop despite
consistent fluid resuscitation 
Histolopatholog
cortical tubular atrophy, i
renal medulla, and loss of tubular architecture combined with epithelial 
sloughing.  The kidney glomeruli remained uninjured.  
did not deviate from controls were the wet
and alkaline phosphatase levels.  The increase in aspartate 
aminotransferase (AST) was insignificant.  The rise in international 
normalized ration (INR), partial thrombop
prothrombin time (PT) were clinically significant, but statistic
not seen as outliers 
[5]. 
ical assessment of the kidneys showed early 
nterstitial and perivascular edema, damage in the 
Paramete
-to-dry ratio as well as bilirubin 
lastin time (PTT), and 
[5]. 
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 Histolopathological assessment of the liver revealed extensive 
interstitial edema 
septa and portal areas, accompanied by pronounced leukocyte infiltration 
into these regions.  Sinusoid congestion as well as paracentral necrosis 
was observed along with loss of cellular integrity imm
surrounding the central vein.  The wet
controls in either the kidney or liver 
Table 5 demonstrates l
(SvO2), which points
experiments decreases were also seen in blood glucose levels, and to a 
lesser extent in chloride and sodium.  At the acute injury phase, lactate 
rose, and then dropped as a result of animal resuscitation, only to rise 
again toward the end of the exp
ill [5]. 
Histopathological analysis of the intestine 
epithelium degradation, sloughing of the lamina propria onto the intestinal 
lumen, and flattened denuded 
throughout the connective tissue regions of the lobular 
-to-dry ratio did not deviate from the 
[5]. 
arge decreases in venous oxygen saturation 
 to decreased systemic oxygenation.  Thro
eriments as animals became increasingly 
showed surface 
villi.  Other changes in the upper right 
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ediately 
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 mucosal compartment included signs of hypoxia with restricted blood 
flow through the end
congestion. The substantially high wet
controls correlates with the presence of the edema 
vessels present in the serosa, a typical d
Both the ascites and plasma data collected pointed to a marked 
increase in the various cytokines present, as a result of the immune 
response upregulation follo
BALF contained TNF
TNF-α, IL-1β, IL
when comparing baseline values to values at the conclusion of the 
experiments.  While TNF
showed the opposite trend [5].
 
-capillary bed, caused by small blood capillary 
-to-dry ratio as compared with 
and dilated lymph 
emarcation of acute peritonitis 
wing disease onset.  Table 6 presents this data. 
-α, IL-1β, IL-6, IL-8, IL-10, and IL-12.  Over time, 
-6, IL-8, and IL-14 levels were substantially increased 
-α and IL-1β levels rose systemically, IL
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DISCUSSION 
 The ultimate goal of preclinical studies of potential sepsis 
treatments is for these studies to bear clinical relevance to humans so that 
they may eventually be translated into human trials and future effective 
treatments.  Presently, animal models which have been employed may 
have proven effective in particular organisms, but due to the deviation 
from human pathophysiology and disease pathogenesis, many such studies 
have proven deleterious in humans or have resulted in a stalemate in terms 
of new treatment options for sepsis and its progression.  Various scientists 
continue to discuss the relevance of several crucial factors in deciding 
which animals to use, how to induce injury, and management of disease 
progression.  This includes consideration of genetic and sexual variability 
between humans and species being studied, as some respond differently to 
differing strains of viruses or bacteria, which may prove to be significant 
in how sepsis unravels. Similarly, the pre-disease health conditions of 
model organisms must be taken into account, as young animals are more 
likely to not have been exposed to previous insults.  Pre-treated animals 
should also be viewed with skepticism because ill patients are often not 
pre-treated by the time disease onset is identified.  Knock-out animals, 
such as mice which have been used throughout several studies, may have 
alternative genetic pathways to compensate for the insult inflicted during 
studies, the effects of which remain unknown.  When small organisms are 
used, sometimes it becomes impossible to provide supportive therapy, 
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which may in itself become the cause of morality (i.e., lack of fluid 
resuscitation).  Additionally, antibiotic agents must be used throughout 
effective studies because severely infected septic patients will generally 
always be treated with antibiotics.  Furthermore, the basic aim of the study 
is to test the efficacy of various antibiotic and drug therapies, hence the 
need for a model organism whose response to particular drug treatments 
will mimic that of a human.  In order to pinpoint such a model, drug 
dosage and virulence must be carefully measured [8]. Finally, because 
human sepsis often progresses relatively slowly in a chronic state, utilizing 
rapidly fatal models resulting from acute septic shock in which animal 
mortality is seen within only twelve hours may mask the manifestations of 
a true clinical septic response [9]. 
The animal model in this study complies with the majority of the 
aforementioned standards.  However, using only female pigs may have 
limited the spectrum of results obtained due to the fact that gender was not 
randomized.  Introducing comorbidities into the study, such as diabetes 
and COPD, which often complicate the evolution of human sepsis, may be 
useful for future research.  Also, the use of only healthy adolescent pigs 
may not be fully representational of the true mean age (65 years of age) at 
which human sepsis is most likely to occur.  On the other hand, the 
anatomy and physiology of pigs is similar to that of humans, which also 
allowed for replication of relevant etiology in this study.  Mechanical 
ventilation, fluid resuscitation, and antibiotic therapy mimic standard 
19 
 
intensive care unit clinical procedures which human patients recieve.  
Finally, each experiment was conducted over a length of time sufficient 
for generating data on markers that manifest themselves in a true case of 
human sepsis.  Abiding by these guidelines proved to be effective in 
generating the multiple organ injury/dysfunction as well as systemic 
inflammatory responses, both of which are classic hallmarks in the 
pathogenesis of sepsis. 
Inflammatory Mediators and Coagulation 
Because sepsis is a dysfunction in the mechanism which normally 
maintains homeostasis, pro-inflammatory cytokines (IL-1, IL-6, and TNF) 
can slow down apoptosis as much as in activated neutrophils and 
macrophages [11].  Intestinal epithelium, as well as other tissues may 
suffer accelerated apoptosis, furthering tissue injury.   
In this study, increase in TNF-α and decrease in IL-6 mirrored the 
profile of patients with severe septic shock.  Because IL-12 is required for 
resistance to bacterial peritonitis [10], the decrease of this cytokine in our 
animals, as well as IL-10 found within the peritoneal fluid and BALF [5], 
shows the progressive suppression of both innate and T cell-dependent 
defense mechanisms, which are a critical phase in organ injury and 
consequently septic shock.   
An increase in inflammation and coagulation occurs through 
induced pro-inflammatory mediators, endothelial injury, tissue factor (TF) 
release, and thrombin production.  On the other hand fibrinogenolysis, 
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which normally counteracts pro-clotting forces, becomes suppressed [14].  
The introduced endotoxin becomes bound to receptors found in 
mononuclear leucocytes (monocytes and macrophages), resulting in the 
secretion of multiple cytokines.  When there is over-production of such 
cytokines, interleukin-1 (IL-1) and tumor necrosis factor (TNF) are the 
first cytokines to exhibit adverse effects.  Cytokines produce specific 
effects through pathways using nitric oxide (NO), the metabolites of the 
arachidonic acid (prostaglandins, thromboxane and leukotrienes), and 
platelet activating factor (PAF).  IL-1 and TNF stimulate the production of 
other cytokines, producing a vast cascade effect [13], showing that 
cytokines play a role in both coagulation abnormalities and vascular 
endothelial activation, both of which contribute to organ dysfunction as 
shown in Figure 1 below.  Additionally, Protein C produces an essential 
anti-thrombotic pathway. Activation of this protein not only helps prevent 
excessive blood coagulation but it also diminishes the inflammatory response.  
In sepsis, activation of protein C is defective, resulting in inappropriate blood 
coagulation leading to inadequate organ perfusion and organ failure [12].  As 
previously discussed, this supports the effectiveness of current protein C 
therapies implicated in the treatment of sepsis.   
 Prolonged PT, PTT, and elevated INR levels along with 
histopathologic confirmation of microthrombosis within all organs, verified 
coagulation abnormalities in all animals [5].  The decrease in platelet count of 
all animals in this study are consistent with the role that activated platelets 
play in generating microvascular clots, propagated in the inflammatory 
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response, leading to the thrombocytopenia observed in critically ill patients, 
due to platelet consumption [13]. 
 
Figure 1: Progression of the inflammation-coagulation autoamplification 
loop [31]. 
 
Pulmonary Function 
Acute respiratory distress syndrome (ARDS) is associated with 
increased mortality rates, with sepsis being the most frequent risk factor 
for ARDS. The two conditions share the same complex mediator-
facilitated process involving different cellular components and an 
important inter-relation between inflammation and coagulation.  As a 
result of the action of various mediators, capillary permeability changes 
appear, resulting in pulmonary edema, as histopathology analysis in this 
study shows, and an increase in extravascular lung water, as observed in 
comparison with controls within this study.  Mortality rates from ARDS 
remain at 30–50%, with outcome usually better in trauma than in sepsis 
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[15].  In 80% of cases death is due to multiple organ failure, reflecting the 
systemic nature of the disease’s progression [15].   
Intraalveolar and intravascular fibrin deposition are a common 
feature found in acute lung injury (ALI) or acute respiratory distress 
syndrome (ARDS) [17].  These fibrin deposits increase vascular 
permeability, which in turn exaggerates the inflammatory response, further 
activating endothelial cells to produce proinflammatory cytokines and 
other mediators [16].  There was evidence of this in a study which 
confirmed the presence of TNF-α, IL-1β, IL-6, IL-8, and IL-10 in BALF 
[5].  From here an accumulation of activated neutrophils and modulating 
immunoregulatory responses become stimulated in the lung. The 
endotoxin implantation in this study is responsible for producing fibrin 
deposits in the lung and other organs, and these widespread intravascular 
alterations are believed to have contributed to the multiple organ 
dysfunction seen in this model of sepsis.  
Increases in peak and plateau pressures along with a marked 
decrease in static compliance and P/F ratio provided proof of acute lung 
injury.  Anatomical findings of alveolar collapse (shown in Figure 2 
below), hyaline membrane formation, and accumulation of lymphocytes 
were consistent with profiles of traditional autopsy findings in severely 
septic patients [5].  Subsequent fibrosis leads to further thickened alveolar 
septa.   
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Kidney Function 
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increased plasma levels of epinephrine, of the renin-angiotensin 
aldosterone system (RAAS), with elevated levels of angiotensin II and a 
rise in vasopressin levels are present as part of the host response [18].  
These shifts contribute to the clinical manifestations of sepsis, including 
the hemodynamic changes characterized by vasodilation, a hyperdynamic 
circulation, and microcirculatory changes contributing to inefficient 
oxygen extraction [18].  Although often there is no consistent or typical 
renal histopathological pattern indicating the severity of kidney injury 
[19], the renal histopathology observed pertained to the convoluted 
tubules’ cortex as well as interstitial and perivascular edema [5]. 
Ultimately, sepsis causes a reduction in mean arterial pressure 
(MAP), which affects systemic vasculature as mean arterial pressure 
decreases below the auto-regulatory range in which renal blood flow is 
normally maintained [19].  This leads to renal vasoconstriction.  This 
study demonstrated a gradual drop in urine output in all animals, 
remaining substantially lower than baseline measurements despite fluid 
resuscitation [5]. 
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Figure 3: Detailed progression of acute renal failure (ARF) as 
seen in septic shock [32]. 
 
Liver Function  
The liver plays a major role in host defense mechanisms in septic 
patients.  Here, Kupffer cells perform bacterial scavenging, inactivate 
bacterial products, and clear or produce inflammatory mediators.  
Hepatocytes shift their metabolic pathway toward gluconeogenesis, 
amino-acid uptake, and increased synthesis of complement and 
coagulation factors and protease inhibitors with the help of receptors for a 
variety of proinflammatory cytokines [22].  In sepsis, the acute-phase 
protein (APP) response contributes to an upregulated coagulation state by 
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inhibiting protein C and decreasing liver synthesis of antithrombin and 
protein C [21].  The liver’s increased production of thrombin-activated 
fibrinolytic inhibitor promotes fibrinolysis inhibition.  Such hepatic 
inflammatory and altered coagulation in sepsis may have harmful effects 
on the liver as Figure 4 reveals.  This study showed hepatic dysfunction 
which causes diminished lactate clearance, via the elevated serum lactate 
level observed at the conclusion of the experiment [5].  Activated Kupffer 
cells that release chemokines, attract blood neutrophils into the liver, and 
activate them, may in turn cause microcirculatory instability, hepatocyte 
injury, fibrin deposition, endotoxin spillover, and multiple organ failure 
[22]. 
 
Figure 4: Hepatic cytokine production in sepsis and extrahepatic 
bacterial infections. 
Microcirculatory instability often leads to capillary leakage, 
manifested as low serum albumin and total protein levels as seen in this 
27 
 
study [5].  Elevated AST and INR values in this study correspond with 
liver injury as seen in human septic shock [23].  As literature indicates, 
hepatosplanchnic hypoperfusion, which often leads to such hepatic 
dysfunction, may be reversed with fluid support [23].   Histopathological 
observation showed non-specific damage, but was consistent with the 
typical presence of centriacinar necrosis, prominent Kuppfer and 
endothelial cells, and minimal inflammation [20] [5]. 
Gastrointestinal Function  
 The difficulty in assessing gut function at the bedside has left no 
clear indicator(s) of acute intestinal dysfunction.  However, the gut has 
been introduced as an important initiator of organ injury following septic 
shock as explained further [24].  This may occur when the overgrowth of 
bacteria in the gastrointestinal tract compromises the normal barrier 
function of the gut and subsequently allows bacteria and endotoxins to be 
translocated into the systemic circulation [24], which is shown in Figure 4.  
This causes an extension of septic shock. 
 This study was able to show an increase in inflammatory peritoneal 
fluid and intestinal edema substantial enough to contribute to abdominal 
compartment syndrome [5].  Because this syndrome often affects the 
function of other organs, it is suggestive of a pathway by which intestinal 
injury leads to a worsening prognosis for severe sepsis and septic shock 
patients [5].   Evidence of significant intestinal edema and a large-scale 
volume of ascites suggest intestinal injury.  This is confirmed by observed 
28 
 
widespread histopathologic injury as substantiated by denudated villi and 
epithelial sloughing [5]. 
CONCLUSION 
This translational animal model of trauma-induced shock and 
bacterial sepsis successfully mimics the human pathophysiology of 
traumatic and septic shock.  It can help direct future patient treatment 
through improved diagnosis, clinical care management, and effective 
therapy. 
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 CAPSTONE SUMMARY 
I began conducting research at the Cardiopulmonary Critical Care 
laboratory at Upstate Medical University beginning in June 2009.  
Through working with medical residents, doctors, students, and various 
researchers, I have had the opportunity to participate in translational 
research conducted on Yorkshire pigs in order to investigate the evolution 
of sepsis and septic shock to multiple organ dysfunction syndrome 
(MODS).  Translational research is unique and advantageous in that 
scientists provide clinicians with new treatments and tools for patient care 
and for assessment of their impact, while clinical researchers make novel 
observations about the nature and progression of disease, often stimulating 
cutting edge research investigations.  Elucidating the physiological 
progression of this disease process is important for generating relevant 
data regarding improved preventative, monitoring, and treatment options, 
which may hopeful be used in future clinical trials on humans. 
Human sepsis is typically caused by a site of infection containing 
replicating bacteria that persists for an extensive period of time.  It is a 
syndrome that usually evolves in a continuum from systemic 
inflammatory response syndrome (SIRS) to sepsis combined with organ 
dysfunction to septic shock.  While various medical treatments have been 
proven effective in the treatment of sepsis in animal models, the only 
current effectual treatment of human sepsis is limited to the use of 
activated protein C.  The complex pathogenesis of human sepsis presents a 
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challenge in precisely duplicating the process of disease development in 
the particular animal models that are currently employed for preclinical 
testing.  The objective of this 48 hour study was to utilize a clinical model 
that accurately replicates severe human sepsis along with gut 
ischemia/reperfusion (the blocking off of blood flow to a particular 
regions followed by subsequent restoration of blood flow to this area), 
further leading to the injury of multiple organs within the time period most 
closely mirroring disease progression in humans. 
Pigs were subjected to a “two-hit” injury involving the clamping of 
the superior mesenteric artery for 30 minutes as well as a laparotomy used 
for insertion of a fecal clot, following appropriate administration of 
anesthetics and ventilation.  Twelve hours after the injury was inflicted, 
the abdomen was reopened, dressed and allowed to drain passively. The 
animals were followed for the remainder of the 48-hour study and 
received treatment with fluids and antibiotics according to standard 
Intensive Care Unit practices. Physiologic parameters, laboratory data, and 
inflammatory mediator levels were collected regularly and recorded 
throughout the study. Hemodynamics, also known as blood flow 
parameters, were stabilized through administration of antibiotics and 
intravenous fluids as needed, while measurements of arterial and mixed 
venous blood gases as well as lung, kidney, liver, renal, and hemodynamic 
function measurements were recorded.  Progression of the abdominal 
compartment syndrome was determined by monitoring bladder pressure 
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changes.  Serial measurements of peritoneal and plasma ascites were also 
taken for evaluation of cytokine concentration, which was important for 
determining the onset, spread, and stage of disease development, seeing as 
cytokines are small cell-signaling protein molecules generated during the 
immune response and are telling of the degree of injury and/or response to 
a physiological insult.  Morphometric analysis, or examination of 
variations in size, shape, and pathology of the organism on a micro and 
macro scale, was carried out using the organ tissues harvested and fixed at 
necropsy.  After 48 hours the animals were sacrificed (if they were not yet 
deceased) with bolus barbiturate and necropsy was performed followed by 
histologic analysis. 
Through watching and emulating operative and post-operative 
techniques, such as inserting catheters, or assisting during a necropsy, I 
was able to fundamentally understand, at the most basic level, how, why, 
and which vital measurements are monitored during experiments and 
translate this knowledge into understanding how numbers correlate with 
the functions of an infected living organism.  Routine questioning and 
hands-on testing of acquired skills by my mentor/advisor ensured that I 
not only understood the significance of my findings, but was able to 
independently explain and measure the necessary information in order to 
carry out my project.   
In combining both sepsis and ischemia reperfusion injury, the 
animal model used in this study should be valid for uncovering the 
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intricate pathophysiological progression of septic shock and its transition 
to multiple organ dysfunction syndrome, as it mirrors the systemic 
inflammation and major organ systems dysfunction seen in humans.  The 
usefulness and validity of this animal model is further evidenced by the 
presence of polymicrobial sepsis in all animals with a progressive 
deterioration of organ function, histopathological and clinical injury, and 
development of acute lung injury and abdominal compartment syndrome 
over the duration of the 48-hour experiments.  Each of these conclusions 
was drawn through the precise observation of increases in multiple 
cytokines within peritoneal and serum fluid, which parallels the 
dysfunction of major organ systems. The novel findings of this study have 
significant implications for the future reduction of mortality from the 
leading cause of hospitalization for adult patients in the intensive care 
unit: sepsis. 
 
 
